Delivery Order SPE2DR25D2109-SPE2DR26F5ZNT
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,659.65 to AmerisourceBergen Drug Corp for the supply of Epidiolex 100 mg/ml solution in 100 ml packs. The contract, which is not set-aside and employs firm fixed price terms, was awarded on December 12, 2025, with an ultimate completion date of January 6, 2026. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,682.50 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Epidiolex 100 mg/ml solution in a 100 ml pack. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 8, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,659.65 delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Epidiolex 100 mg/ml solution in 100ml packs. This is a firm fixed-price contract with an ultimate completion date of January 29, 2026, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was made on a competitive, non-set-aside basis and represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s...
- The Defense Logistics Agency awarded a delivery order valued at $2,523.75 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution in 100 ml packs on September 12, 2025, with an ultimate completion date of October 3, 2025. This is a firm fixed price, non-set-aside contract with performance at the company's Conshohocken, Pennsylvania location. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a delivery order valued at $8,412.50 to AmerisourceBergen Drug Corp for Epidiolex 100 mg/mL solution in 100 mL packs, with an ultimate completion date of November 28, 2025. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving the federal government's medical supply needs,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Epidiolex 100 mg/ml solution in 60 ml packs at a ceiling value of $1,349.88. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The award is expected to be completed by December 10, 2025, with performance originating from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,365.00 to AmerisourceBergen Drug Corp for the supply of Epidiolex 100 mg/mL solution in 100 mL packs. This firm fixed-price delivery order, awarded on August 29, 2025, is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract represents a non-set-aside competitive award, demonstrating the vendor's capability to meet federal...
- The Defense Logistics Agency awarded a $1,280.92 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Epidiolex 100 mg/ml solution in 60ml packs, with an ultimate completion date of October 6, 2025. This firm fixed-price contract was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Epidiolex is an FDA-approved cannabidiol medication used primarily for...
- The Defense Logistics Agency awarded a $1,682.50 delivery order to AmerisourceBergen Drug Corp on October 7, 2025, for Epidiolex 100 mg/ml solution in 100 ml packs, with a completion date of October 29, 2025. This competitively awarded, firm fixed-price order represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The order will be fulfilled from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Epidiolex 100 mg/ml solution (100 ml pack) with a ceiling value of $8,865.50 under a firm fixed-price contract. The award was made on December 30, 2025, with an ultimate completion date of January 22, 2026. This non-set-aside competitive award represents a single delivery order for the anti-seizure medication, with performance occurring at AmerisourceBergen's Conshohocken, Pennsylvania facility. This...
- SPE2DR25D2109Indefinite Delivery Contract
- SPE2DR25D2109-SPE2DR26F5ZNTDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,773.10 to AmerisourceBergen Drug Corp (Conshohocken, PA) on January 6, 2026, for the supply of Epidiolex 100 mg/ml oral solution in 100 ml packs. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of January 28, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical pharmaceutical distributor for federal medical procurement needs. The order was issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which provides a comprehensive vehicle for delivering pharmaceuticals and medical supplies globally to support military healthcare programs. Epidiolex is an FDA-approved cannabidiol (CBD) product indicated for seizure management in specific epilepsy conditions, and this delivery order represents a routine replenishment of inventory to support military healthcare facilities and defense health operations. The contract carries no set-aside designation, confirming AmerisourceBergen Drug Corp's award through full and open competition. As a major pharmaceutical distributor with extensive experience fulfilling federal medical supply requirements, the company maintains a significant portfolio of delivery orders across multiple therapeutic domains with the Defense Logistics Agency, supporting the military health system's pharmaceutical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 1/5/26 |